Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes

View ORCID ProfileMohammad Ali Ashraf, Nasim Shokouhi, Elham Shirali, Fateme Davari-tanha, Omeed Memar, View ORCID ProfileAlireza Kamalipour, Ayein Azarnoush, Avin Mabadi, Adele Ossareh, Milad Sanginabadi, Talat Mokhtari Azad, Leila Aghaghazvini, Sara Ghaderkhani, Tahereh Poordast, Alieh Pourdast, Pershang Nazemi
doi: https://doi.org/10.1101/2020.04.20.20072421
Mohammad Ali Ashraf
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammad Ali Ashraf
Nasim Shokouhi
2Yas complex hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elham Shirali
2Yas complex hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fateme Davari-tanha
2Yas complex hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omeed Memar
3Academic Dermatology and Skin Cancer Institute, 130 N Garland Ct, Chicago, IL 60602
M.D. Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alireza Kamalipour
4Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, CA, United States
5MPH Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alireza Kamalipour
Ayein Azarnoush
6Alborz University of Medical Sciences, Karaj, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avin Mabadi
7Iran University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adele Ossareh
8Department of Statistics, Shahid Beheshti University, Tehran, Iran
M.Sc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milad Sanginabadi
9Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talat Mokhtari Azad
10the National Influenza Centre, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leila Aghaghazvini
9Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Ghaderkhani
2Yas complex hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tahereh Poordast
11Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alieh Pourdast
2Yas complex hospital, Tehran University of Medical Sciences, Tehran, Iran
12Iranian Research Center for HIV/AIDS (IRCHA), Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pershang Nazemi
2Yas complex hospital, Tehran University of Medical Sciences, Tehran, Iran
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nazemipershang{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose There is a growing need for information regarding the recent coronavirus disease of 2019 (Covid-19). We present a comprehensive report of Covid-19 patients in Iran.

Methods One hundred hospitalized patients with Covid-19 were studied. Data on potential source of exposure, demographic, clinical, and paraclinical features, therapy outcome, and post-discharge follow-up were analyzed.

Results The median age of the patients was 58 years, and the majority of the patients (72.7%) were above 50 years of age. Fever was present in 45.2% of the patients on admission. The most common clinical symptoms were shortness of breath (74%) and cough (68%). Most patients had elevated C-reactive protein (92.3%), elevated erythrocyte sedimentation rate (82.9%), lymphocytopenia (74.2 %) on admission. Lower lobes of the lung were most commonly involved, and ground-glass opacity (81.8%) was the most frequent finding in CT scans. The administration of hydroxychloroquine improved the clinical outcome of the patients. Lopinavir/ritonavir was efficacious at younger ages. Of the 70 discharged patients, 40% had symptom relapse, (8.6%) were readmitted to the hospital, and 3 patients (4.3%) died.

Conclusion This report demonstrates a heterogeneous nature of clinical manifestations in patients affected with Covid-19. The most common presenting symptoms are non-specific, so attention should be made on broader testing, especially in age groups with the greatest risk and younger individuals who can serve as carriers of the disease. Hydroxychloroquine and lopinavir/ritonavir (in younger age group) can be potential treatment options. Finally, patients discharged from the hospital should be followed up because of potential symptom relapse.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was not funded by any agency or organization.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data regarding the manuscript and supplementary files are available and will be provided as request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
Mohammad Ali Ashraf, Nasim Shokouhi, Elham Shirali, Fateme Davari-tanha, Omeed Memar, Alireza Kamalipour, Ayein Azarnoush, Avin Mabadi, Adele Ossareh, Milad Sanginabadi, Talat Mokhtari Azad, Leila Aghaghazvini, Sara Ghaderkhani, Tahereh Poordast, Alieh Pourdast, Pershang Nazemi
medRxiv 2020.04.20.20072421; doi: https://doi.org/10.1101/2020.04.20.20072421
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
Mohammad Ali Ashraf, Nasim Shokouhi, Elham Shirali, Fateme Davari-tanha, Omeed Memar, Alireza Kamalipour, Ayein Azarnoush, Avin Mabadi, Adele Ossareh, Milad Sanginabadi, Talat Mokhtari Azad, Leila Aghaghazvini, Sara Ghaderkhani, Tahereh Poordast, Alieh Pourdast, Pershang Nazemi
medRxiv 2020.04.20.20072421; doi: https://doi.org/10.1101/2020.04.20.20072421

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)